Appetite suppression and reduced fluid intake People on semaglutide eat less
Depending on the study, somewhere between one in three and one in two participants may receive placebo, and neither you nor your study team knows which arm you are in during the trial
While clinical trials are ongoing, a study published in Alzheimers & Dementia in October 2024 found that people with Type 2 diabetes who used semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) had a lower risk of a first-time diagnosis of Alzheimers disease, compared to people who used insulin, other GLP-1s, or other diabetes medicines
Bao W, Morimoto K, Hasegawa T, Sasaki N, Yamashita T, Hirata K, Okita Y, Okada K (2014) Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats
The cardiovascular benefits
Eriodictyol ameliorates lipopolysaccharide-induced acute lung injury by suppressing the inflammatory COX-2/NLRP3/NF-B pathway in mice